**Question:** Induction agent of choice in a child with cyanotic heart disease -

A. Propofol
B. Thiopentone
C. Midazolam
D. Sufentanil

**Correct Answer:** B. Thiopentone

**Core Concept:**
In children with cyanotic heart diseases, the choice of anesthetic induction agent is crucial to ensure proper hemodynamics and minimize the risk of adverse events. Cyanotic heart diseases refer to congenital heart defects where deoxygenated blood bypasses the lungs, resulting in cyanosis (blue discoloration of skin). These patients require special considerations when administering anesthesia.

**Why the Correct Answer is Right:**
Thiopentone (phenytoin sodium) is a commonly used intravenous anesthetic agent for induction of general anesthesia in pediatric patients. It is preferred in cases of cyanotic heart disease due to several reasons:

1. **Its hemodynamic effects:** Thiopentone is a short-acting barbiturate that has a rapid onset of action and minimal cardiovascular effects. It does not cause significant hypotension, bradycardia, or prolongation of QT interval, which are potential issues in cyanotic children due to their hemodynamic instability.

2. **Its respiratory effects:** Thiopentone does not cause significant respiratory depression, which is crucial in maintaining adequate gas exchange in children with cyanotic heart disease.

**Why Each Wrong Option is Incorrect:**

A. Propofol: Although a popular induction agent, propofol can cause significant hypotension and bradycardia in cyanotic children due to its potent vasodilatory and chronotropic effects. Additionally, it may lead to respiratory depression, which is undesirable in these patients.

C. Midazolam: Midazolam is another benzodiazepine that, like propofol, can cause significant hypotension, bradycardia, and respiratory depression in cyanotic children due to its potent vasodilatory and chronotropic effects.

D. Sufentanil: Sufentanil is a potent fentanyl analog with similar vasodilatory and chronotropic effects. Like propofol and midazolam, it can cause significant hypotension, bradycardia, and respiratory depression in cyanotic children, making it an unsuitable option.

**Clinical Pearl:**
When managing anesthesia in children with cyanotic heart disease, it is essential to choose an induction agent with minimal cardiovascular and respiratory depressant effects. Thiopentone is the most suitable option among the given choices due to its minimal cardiovascular and respiratory side effects. Adequate ventilation and adequate oxygenation are crucial for these patients, and thiopentone's lack of significant respiratory and cardiovascular effects makes it the preferred choice in this context.